Production and launch of Favipiravir and Remdesivir in Actover Pharma group

October 20, 2020

Author: Acteropharma

With continuous monitoring of international research and protocols, it was suggested to produce drugs in the treatment of Covid-19 in the Actover group, as a pioneer in the production of drugs needed in COVID-19, the group unveiled two drugs, Remdesivir and Favipiravir.

It should be noted that these two drugs have entered the official list of drugs in Iran.

Last News

Nahaleh Naraqi honors National Doctors Day in Iran

August 28, 2024

Author:

Acteropharma

Nahale Naraghi honors National Doctors Day in Iran, coinciding with Avicenna’s birthday.

Pharmacy Day Appreciation from Nahaleh Naraqi

August 27, 2024

Author:

Acteropharma

Nahale Naraghi honors Pharmacist Day with a special message of gratitude, recognizing the essential role pharmacists play in advancing healthcare and supporting patient well-being

Iranian Gastro Intestinal Cancer

June 1, 2024

Author:

Acteropharma

The first seminar on Gastrointestinal cancer updates was held on May 23 , 2024 in Sari city with the presence of great professors of hematology and oncology, radio-oncology specialists, gastroenterology specialists, etc.